ABSTRACT
A 30-year-old woman, gravida 2, para 1, was referred for nuchal translucency, free beta-human chorionic gonadotropin (β-hCG), and pregnancy-associated plasma protein A (PAPP-A) screening at 12 weeks gestation. The nuchal translucency was increased to 3.8 mm, resulting in a post-test result of 1:15 risk for Down syndrome by a combination of maternal age plus nuchal translucency, and 1:5 by a combination of maternal age plus nuchal translucency plus free β-hCG plus PAPP-A. The patient underwent uncomplicated chorionic villus sampling that demonstrated a normal 46,XY fetus. The patient was then followed-up weekly by ultrasound. At 18 weeks gestation, generalized features of rhizomelic micromelia together with macrocrania and narrow thorax were seen. All fetal long bones were less than 2 standard deviations from the mean value. At that time, DNA analysis was performed on stored villi and a G380R mutation in the locus gene encoding for the fibroblast growth factor receptor 3 on chromosome 4p16.3 was found, leading to a prenatal diagnosis of achondroplasia. The couple opted for termination of pregnancy after counseling. Postmortem X-ray was done and confirmed the ultrasound diagnosis of achondroplasia. This is the second known case of increased nuchal translucency in the first trimester associated with prenatal confirmed diagnosis of fetal osteochondrodysplasia.
KEYWORDS
Nuchal translucency - CVS - DNA analysis - achondroplasia
REFERENCES
-
1
Snijders R J, Noble P, Sebire N, Souka A, Nicolaides K H.
UK multicentric project on assessment of risk for trisomy 21 by maternal age and fetal nuchal translucency at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group.
Lancet.
1998;
352
343-346
-
2
Hyett J A, Perdu M, Sharland G K, Snijders R JM, Nicolaides K H.
Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects.
Ultrasound Obstet Gynecol.
1997;
10
242-246
-
3
Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides K.
Using fetal nuchal translucency to screen for major congenital cardiac defect at 10-14 weeks of gestation: population based cohort study.
BMJ.
1999;
318
81-85
-
4
Souka A P, Snijders R J, Novakov A, Soares W, Nicolaides K H.
Defects and syndromes in chromosomally normal fetuses with increased nuchal thickness at 10-14 weeks of gestation.
Ultrasound Obstet Gynecol.
1998;
11
391-400
-
5
Makrydimas G, Souka A P, Skentou H, Lolis D, Nicolaides K.
Increased nuchal translucency and osteogenesis imperfecta.
Am J Med Genet.
2001;
98
117-120
-
6
Vajo Z, Francomano C A, Wilkin D J.
The molecular and genetic basis of FGFR3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans.
Endocr Rev.
2000;
21
23-39
-
7
Bellus G A, Bamshad M J, Przylepa K A et al..
Severe achondroplasia with developmental delay and achantosis nigricans (SADDan): phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3.
Am J Med Genet.
1999;
85
53-65
-
8
Timor-Trish I E, Monteagudo A, Peisner D B.
High-frequency transvaginal sonographic examination for the potential malformation as assessment of the 9-week to 14-week fetus.
Ultrasound Obstet Gynecol.
1997;
9
392-397
-
9
Fisk N M, Vaughan J, Smidt M, Wigglesworth J.
Transvaginal ultrasound recognition of fetal oedema in the first trimester diagnosis of achondrogenesis.
J Clin Ultrasound.
1991;
19
586-590
-
10
Benacerraf B C, Lister J E, DuPonte B L.
First trimester diagnosis of fetal abnormalities. A report of three cases.
J Reprod Med.
1988;
33
777-780
-
11
Ben Ami M, Perlitz Y, Haddad S, Matilsky M.
Increased nuchal translucency is associated with asphyxiating thoracic dysplasia.
Ultrasound Obstet Gynecol.
1997;
10
297-298
-
12
Otano L, Matayjoshi T, Gadow E C.
Roberts syndrome: first trimester prenatal diagnosis.
Prenat Diagn.
1996;
16
770-771
-
13
Eliyahu S, Weiner E, Lahav D, Shalev E.
Early sonographic diagnosis of Jarcho-Levin syndrome: a prospective screening in one family.
Ultrasound Obstet Gynecol.
1997;
9
314-318
-
14
Den Hollander N S, van der Harten H J, Verneij-Keers C, Niermeijer M F, Wladimiroff J W.
First trimester diagnosis of Blomstrand lethal osteochondrodysplasia.
Am J Med Genet.
1997;
73
345-350
Gabriele TonniM.D. Ph.D.
Department of Obstetrics and Gynaecology, ASL Reggio Emilia, Guastalla Civil Hospital
Via Donatori di Sangue, 42016 Guastalla Reggio Emilia, Italy
